Sinovac Biotech annual current ratio
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Current Ratio Growth & History (SVA)
Sinovac Biotech's current ratio was 4.59 for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.59 | −2.75 | −37.44% |
| 2024 | 2024-12-31 | 7.33 | −1.64 | −18.28% |
| 2023 | 2023-12-31 | 8.97 | −0.03 | −0.29% |
| 2022 | 2022-12-31 | 9.00 | 3.07 | +51.70% |
| 2021 | 2021-12-31 | 5.93 | 3.64 | +158.34% |
| 2020 | 2020-12-31 | 2.30 | −1.71 | −42.74% |
| 2019 | 2019-12-31 | 4.01 | −0.87 | −17.88% |
| 2018 | 2018-12-31 | 4.88 | 2.68 | +121.60% |
| 2017 | 2017-12-31 | 2.20 | 0.23 | +11.66% |
| 2016 | 2016-12-31 | 1.97 | −0.24 | −10.72% |
| 2015 | 2015-12-31 | 2.21 | 0.27 | +13.98% |
| 2014 | 2014-12-31 | 1.94 | −1.26 | −39.38% |
| 2013 | 2013-12-31 | 3.20 | −0.99 | −23.61% |
| 2012 | 2012-12-31 | 4.19 | 0.85 | +25.38% |
| 2011 | 2011-12-31 | 3.34 | 0.13 | +3.99% |
| 2010 | 2010-12-31 | 3.21 | — | — |
Sinovac Biotech quarterly current ratio
Q4.10
Q4.11
Q4.12
Q4.13
Q4.14
Q4.15
Q4.16
Q4.17
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 4.59 | −2.75 | −37.44% |
| Q2 2025 | 2025-06-30 | 2.07 | — | — |
| Q4 2024 | 2024-12-31 | 7.33 | −1.64 | −18.28% |
| Q4 2023 | 2023-12-31 | 8.97 | −0.03 | −0.29% |
| Q4 2022 | 2022-12-31 | 9.00 | 3.07 | +51.70% |
| Q4 2021 | 2021-12-31 | 5.93 | 3.64 | +158.34% |
| Q4 2020 | 2020-12-31 | 2.30 | −1.71 | −42.74% |
| Q4 2019 | 2019-12-31 | 4.01 | −0.87 | −17.88% |
| Q4 2018 | 2018-12-31 | 4.88 | 2.68 | +121.60% |
| Q4 2017 · Dec 31 | 2017-12-31 | 2.20 | 0.23 | +11.66% |
| Q4 2016 | 2016-12-31 | 1.97 | −0.24 | −10.72% |
| Q4 2015 | 2015-12-31 | 2.21 | 0.27 | +13.98% |
| Q4 2014 | 2014-12-31 | 1.94 | −1.26 | −39.38% |
| Q4 2013 | 2013-12-31 | 3.20 | −0.99 | −23.61% |
| Q4 2012 | 2012-12-31 | 4.19 | 0.85 | +25.38% |
| Q4 2011 | 2011-12-31 | 3.34 | 0.13 | +3.99% |
| Q4 2010 | 2010-12-31 | 3.21 | — | — |
Sinovac Biotech current ratio trends
Over the last five fiscal years, Sinovac Biotech's current ratio increased from 2.30 to 4.59, a change of 2.29. The latest reported quarter, Q4 2025, shows 4.59.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗